New ETF Book by Larry Connors - Click here to read more
Sign-up for our FREE Stock Alerts AND NEWSLETTER at www.pennyperformers.com
Jun 30, 2009 -- dELiA*s, Inc. (NASDAQ: DLIA | Quote | Chart | News | PowerRating) and The Yacobian Group, LLC (TYG) are pleased to announce a strategic engagement designed to maximize the impact of dELiA*s' recent operational improvements through the implementation of Yacobian's Customer Interaction Management System(SM) (CIMS).
dELiA*s Inc. is a direct marketing and retail company comprised of two lifestyle brands, dELiA*s and Alloy, primarily targeting teenage girls and young women. dELiA*s has devoted substantial resources for infrastructure, systems/processes, brand positioning, product development, and talent acquisition. Building on these investments, dELiA*s plans to leverage Yacobian's CIMS to help improve in-store execution and provide measurable customer experiences.
dELiA*s Chief Operating Officer, Walter Killough stated, "CIMS is a useful tool that we anticipate will provide us with unique insights into our stores' productivity, both collectively and individually. With Yacobian's ROV(TM) [Return-On-Visit] feature, we will be able to monitor and analyze customer experiences and staff behaviors in and across all stores. CIMS is expected to spotlight and quantify the opportunities for us which will assist our team in determining how best to help drive performance."
Yacobian's CIMS tools are designed with a customer-centric approach that integrates software, management processes, and interaction behaviors to deliver branded customer experiences that increase the number and size of transactions in stores each day. According to Yacobian, CIMS was developed to provide organizations one integrated and aligned customer-centric 'performance scorecard' that enhances, rather than interrupts, existing retail store operations.
TYG's Chief Executive Officer, Toni Yacobian, expressed her enthusiasm, "We are very excited to be a partner with dELiA*s success formula to continue their current business momentum. CIMS makes performance improvement systematic, scalable, and sustainable and will be a key factor in driving dELiA*s on-going success in the retail marketplace."
About The Yacobian Group
The Yacobian Group's promise is to help retailers drive store revenue by systematically increasing Return-On-Visit. For over 25 years, TYG has serviced a broad range of retailers such as Nordstrom, Bloomingdale's, Gucci, CHANEL, Polo Ralph Lauren, Sears, Mitchells/Richards/Marshs, Lord & Taylor, T-Mobile, as well as many others to deliver the branded in-store buying experience customers desire. With the Customer Interaction Management System(SM) (CIMS), retailers drive systematic, measurable, profitable revenue improvement, labor performance, and customer satisfaction.
About dELiA*s, Inc.
dELiA*s, Inc. is a direct marketing and retail company comprised of two lifestyle brands primarily targeting teenage girls and young women. Its brands - dELiA*s and Alloy - generate revenue by selling apparel, accessories, footwear and room furnishings to consumers through direct mail catalogs, websites, and dELiA*s mall-based specialty retail stores.
Jun 30, 2009 -- Helix Wind, Corp. (OTCBB: HLXW | Quote | Chart | News | PowerRating) has added smart grid technology to its line of Small Wind Vertical Axis Turbines to manage performance and uptime of Helix Wind systems. The new monitoring system named Helix Wind WTMS (Wind Turbine Monitoring System) is a solution enhancement to any Helix Wind turbine. The system monitors, records, and reports a broad variety of performance metrics in real time, including: wind speed, turbine output, inverter data, generator frequency, and a variety of other variables. Phase 1 of the platform will monitor and report information to Helix Wind's Network Operating Center (HNOC). The unit will be sold in two configurations. The standard unit for wired Ethernet connection retails for $1,200.00 and with the addition of a wireless based enhancement retails for $1,500.00.
"The Helix WTMS smart grid technology is compatible with all Helix Wind Turbines. Uptime, reliability, and accountability, are the hallmarks of all Helix Wind solutions and by adding an additional smart feature enhancement to the Helix product line, Helix will offer a broader array of managed solutions," said Helix Wind Chairman & President Scott Weinbrandt. "This is the first phase of smart grid technology solutions to come from Helix Wind."
About Helix
Helix Wind is a global renewable energy company. Helix Wind is engaged in the design, manufacturing and sale of small wind vertical axis turbines designed to generate 300W, 1kW, 2.0kW, 4.0kW, and 50kW of clean, renewable electricity.
Jun 30, 2009 -- POZEN Inc. (NASDAQ: POZN), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO(TM) (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006. Pending regulatory approval, the proposed trade name is VIMOVO and the proposed indications are for the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk for developing NSAID-associated ulcers.
The NDA submission is based on data from a comprehensive clinical trials program. POZEN conducted two pivotal studies (301/302) under a special protocol assessment agreed with the FDA, which met their primary endpoints. In the 301/302 studies, significantly fewer subjects taking VIMOVO experienced endoscopically confirmed gastric ulcers compared to subjects receiving EC naproxen. The primary endpoint was the cumulative incidence of gastric ulcers through six months. In each of the trials, approximately 400 subjects received either VIMOVO or EC naproxen (500 mg), twice daily, over a six-month treatment period. Subjects underwent upper endoscopies at baseline and at one, three, and six months. Upon the FDA's acceptance for filing of the NDA, a $10 million milestone payment from AstraZeneca will be payable to POZEN.
About Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease caused by the breakdown and eventual loss of the cartilage of one or more joints. Osteoarthritis is the most common form of arthritis and the most common cause of chronic pain, affecting nearly 140 million individuals worldwide,(1) and impacting approximately 18% of women and 9.6% of men aged 60 and above.(2,3) A combination of factors can contribute to osteoarthritis, including being overweight, aging, joint injury or stress, heredity and muscle weakness.(4) Osteoarthritis commonly affects the hands, feet, spine or large weight-bearing joints, such as the hips and knees.(5) In the U.S., the average direct cost of osteoarthritis is about $2,600 per year out-of-pocket expenses. Total annual disease costs are $5,700 (2000) and job-related osteoarthritis costs are $3.4 to $13.2 billion per year.(6)
About POZEN
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for Treximet(R), which was approved in 2008 by the United States Food and Drug Administration for the acute treatment of migraine attacks, with or without aura, in adults, and with AstraZeneca for VIMOVO(TM), a proprietary fixed dose combination of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN".
Jun 30, 2009 -- UTStarcom, Inc. (NASDAQ: UTSI | Quote | Chart | News | PowerRating) was named the leading Internet Protocol Television (IPTV) provider in Asia in Multimedia Research Group's (MRG, Inc.) latest Global IPTV Market Leaders Report. The in-depth analysis tracks the top 100 IPTV vendors in 24 regional sub-segments. UTStarcom's strategic IPTV deployments and strong subscriber gains drove the company's rise to the top in the Access, Video-on-Demand (VOD), Set-top-Boxes, Middleware and Content Protection categories.
"UTStarcom's Asia deployments have moved it into the first place ranking in five key areas of our Market Leaders Report," said Jose Alvear, IPTV Analyst at MRG. "This kind of regional category takeover is unprecedented, and illustrates how IPTV providers are successfully applying their market-specific technology innovation and experience."
UTStarcom pioneered IPTV in China when it introduced its RollingStream(R) end-to-end IPTV system in 2005. As of March 2009, UTStarcom's RollingStream supported more than 1.32 million live IPTV subscribers globally. In 2008, UTStarcom partnered with Guangxi Telecom Company, a wholly-owned subsidiary of China Telecom, to deploy the first IPTV-based digital signage solution in 14 Guangxi cities. UTStarcom was also among the first to deliver the Olympic Games via IPTV to China viewers during summer 2008. This April, the company was selected as the only technology supplier for the first mobile television system across Hainan province, driven by China Telecom's Hainan branch.
UTStarcom is also a recognized IPTV leader throughout the Indian subcontinent. The company partnered with Aksh Optifibre Ltd. in 2007 to deliver the first commercial IPTV service in Delhi through Mahanagar Telephone Nigam Ltd. (MTNL). With UTStarcom's continued partnership, Aksh set an agreement with Bharat Sanchar Nigam Limited (BSNL) to offer its iControl IPTV service in 20 cities across India and additionally in Mumbai with MTNL. UTStarcom also has a long-standing relationship with Bharti Airtel in Delhi NCR. Additionally, UTStarcom's RollingStream platform is being used by Sri Lanka Telecom to deliver IPTV services in the city of Colombo, Sri Lanka.
About UTStarcom, Inc.
UTStarcom is a global leader in IP-based, end-to-end networking solutions and international service and support. The company sells its solutions to operators in both emerging and established telecommunications markets around the world. UTStarcom enables its customers to rapidly deploy revenue-generating access services using their existing infrastructure, while providing a migration path to cost-efficient, end-to-end IP networks. The company was founded in 1991 and is headquartered in Alameda, California.
About Multimedia Research Group
MRG, Inc. provides the Digital, Media and Financial Industries with Market Tracking Services, Custom Consulting and Published Market Intelligence and Technology Reports.
About PennyPerformers.com
PennyPerformers.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.
Penny Performers email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Penny Performers Report home page at www.PennyPerformers.com and select the "join now" button.
Join us at www.PennyPerformers.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. PennyPerformers.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyPerformers.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. PennyPerformers.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), PennyPerformers.com is owned and operated by PennyPerformers.com. Neither PennyPerformers.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since PennyPerformers.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in PennyPerformers.com statements and opinions and such statements and opinions cannot be considered independent. PennyPerformers.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. PennyPerformers.com services are often paid for using free-trading shares. PennyPerformers.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: www.PennyPerformers.com/disclaimer.htm
For More Information Regarding Penny Performers, Contact Jason A. Hilton at: Rochester, Ny 14609 Office: (866)704-0122 Email: Jason@Newmediaadvisorsllc.com
CONTACT: Jason A. Hilton, New Media Advisors LLC Tel: +1 866 704 0122 e-mail: Jason@Newmediaadvisorsllc.com PennyPerformers.com e-mail: info@pennyperforemrs.com WWW: http://www.PennyPerformers.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
